Your browser doesn't support javascript.
loading
RUNX1::ETO translocations must precede CSF3R mutations to promote acute myeloid leukemia development.
Carratt, Sarah A; Kong, Garth L; Coblentz, Cody; Schonrock, Zachary; Maloney, Lauren; Weeder, Ben; Yashar, Will; Callahan, Rowan; Blaylock, Hunter; Coleman, Colin; Coleman, Dan; Braun, Theodore P; Maxson, Julia E.
Afiliación
  • Carratt SA; Division of Oncologic Sciences, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.
  • Kong GL; Division of Oncologic Sciences, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.
  • Coblentz C; Division of Oncologic Sciences, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.
  • Schonrock Z; Division of Oncologic Sciences, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.
  • Maloney L; Division of Oncologic Sciences, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.
  • Weeder B; Division of Oncologic Sciences, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.
  • Yashar W; Division of Oncologic Sciences, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.
  • Callahan R; Division of Oncologic Sciences, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.
  • Blaylock H; Division of Oncologic Sciences, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.
  • Coleman C; Division of Oncologic Sciences, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.
  • Coleman D; Division of Oncologic Sciences, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.
  • Braun TP; Division of Oncologic Sciences, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA. braunt@ohsu.edu.
  • Maxson JE; Division of Hematology & Medical Oncology, Oregon Health & Science University, Portland, OR, 97239, USA. braunt@ohsu.edu.
Leukemia ; 37(5): 1141-1146, 2023 05.
Article en En | MEDLINE | ID: mdl-36894620
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Subunidad alfa 2 del Factor de Unión al Sitio Principal Límite: Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Subunidad alfa 2 del Factor de Unión al Sitio Principal Límite: Humans Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos